GlassScriptPhysician profile
Mesk Alrais
NPI 1093210163
$1,591.08
in general payments reported to CMS, 2019-2025
21 companies · $466 in 2025
The $466 reported for 2025 was more than what 79% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $269 · 2023: $626 · 2024: $231 · 2025: $466.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,323.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,322.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $224.10 | 2022-2025 | Ligasure, V-Loc 180 |
| Evofem Biosciences, INC. | $172.42 | 2022-2025 | Phexxi, Solosec, Phexx |
| Sage Therapeutics, LLC | $172.25 | 2024-2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $148.54 | 2023-2025 | Coolseal Generator, Thinprep 2000 Processor, Aptima |
| Mayne Pharma Commercial LLC | $98.47 | 2023-2024 | |
| Astellas Pharma US INC | $96.83 | 2023-2025 | Veozah |
| Sumitomo Pharma America, INC. | $88.28 | 2023 | Myfembree |
| Organon LLC | $84.53 | 2022-2025 | Nexplanon |
| Exeltis, USA INC. | $66.20 | 2022-2025 | Slynd, Tyblume |
| Ethicon US, LLC | $65.61 | 2023 | Enseal |
| Smith+Nephew, INC. | $63.46 | 2022-2024 | Pico 7 |
| Exact Sciences Corporation | $60.02 | 2025 | Cologuard Collection Kit |
| Supernus Pharmaceuticals, INC. | $54.93 | 2025 | Qelbree |
| Abbvie INC. | $44.53 | 2022-2023 | Lo Loestrin Fe, Orilissa |
| Millicent US INC | $26.75 | 2023 | Femring, Intrarosa |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $25.63 | 2022 | |
| Alexion Pharmaceuticals, INC. | $24.38 | 2022 | |
| Aspira Women'S Health INC | $20.22 | 2024 | Ova1 |
| Pfizer INC. | $20.00 | 2023 | |
| Shield Therapeutics INC | $18.02 | 2023 | Accrufer |
| Optumhealth Care Solutions, LLC | $15.91 | 2023 | Zyno Solutions, Vivify Health Care Team Portal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mesk Alrais listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.